Koshinski Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-724
Closed -$200K – 562
2022
Q4
$200K Sell
724
-42
-5% -$11.9K 0.02% 566
2022
Q3
$205K Buy
+766
New +$163K 0.02% 491
2022
Q2
– Sell
-888
Closed -$187K – 712
2022
Q1
$187K Buy
888
+14
+2% +$3.04K 0.02% 605
2021
Q4
$210K Sell
874
-40
-4% -$10.3K 0.02% 610
2021
Q3
$259K Buy
914
+27
+3% +$8.85K 0.02% 542
2021
Q2
$307K Sell
887
-62
-7% -$18.8K 0.04% 429
2021
Q1
$265K Buy
949
+18
+2% +$4.85K 0.03% 508
2020
Q4
$228K Sell
931
-190
-17% -$49K 0.03% 493
2020
Q3
$327K Buy
1,121
+128
+13% +$35.7K 0.04% 379
2020
Q2
$266K Buy
993
+2
+0.2% +$601 0.04% 411
2020
Q1
$314K Sell
991
-662
-40% -$201K 0.07% 335
2019
Q4
$489K Buy
+1,653
New +$459K 0.08% 310
2019
Q3
– Sell
-1,055
Closed -$247K – 160
2019
Q2
$247K Buy
+1,055
New +$244K 0.1% 228
2018
Q4
– Sell
-714
Closed -$252K – 416
2018
Q3
$252K Buy
+714
New +$246K 0.04% 458

Other funds holding BIIB

Koshinski Asset Management's BIIB Position: Q1 2023 in Review

Koshinski Asset Management sold out of Biogen (BIIB) in Q1 2023, closing a stake of 724 shares — an estimated $200K sold.

Koshinski Asset Management first reported a position in BIIB in Q3 2018 and held it in 14 quarters. The position peaked at $489K in Q4 2019. 1,001 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.

  • Koshinski Asset Management reported no remaining Biogen position as of Q1 2023 after selling out during the quarter.
  • Koshinski Asset Management sold 724 Biogen shares in Q1 2023, an estimated $200K.
  • Koshinski Asset Management first reported a position in Biogen in Q3 2018 and held it in 14 quarters.
  • Koshinski Asset Management's Biogen position peaked at $489K in Q4 2019.
  • 1,001 funds tracked by Wall St. Rank held Biogen as of Q1 2023.

Based on Koshinski Asset Management's 13F filing for Q1 2023, filed 12 Apr 2023.